Perrigo Company PLC

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Nutraceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Agis Industries
  • CanAm Care
  • Chemagis
  • Clay-Park Labs
  • Cobrek Pharmaceuticals
  • Elan Corporation
  • Elan Pharma International
  • Galpharm Healthcare
  • Geiss
  • Destin & Dunn
  • Geiss
  • Destin & Dunn
  • High Ridge Brands
  • HRA Pharma
  • JB Laboratories
  • Laboratorios Diba
  • Naturwohl Pharma
  • Omega Pharma Invest
  • Onclave Therapeutics Li
  • Orion Laboratories
  • Paddock Laboratories
  • PBM Holdings
  • Peter Black Pharmaceuticals
  • Qualis
  • Ranir
  • Ranir Global Holdings
  • Rosemont Pharmaceuticals
  • Sergeant’s Pet Care Products
  • Unico
  • Velcera
  • Wrafton Laboratories
See more in Biomedtracker

Latest on Perrigo Company PLC

Generics Bulletin

Perrigo Looks To ‘Stabilize, Streamline, Strengthen’

 
• By Malcolm Spicer

Perrigo Co. PLC president and CEO Patrick Lockwood-Taylor begins his second contract with the firm by steering it on its second plan to spur growth since he took the helm. “We’ve made meaningful progr

Scrip

Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary

 
• By Joseph Haas, Vibha Ravi, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Deal Brings AstraZeneca Greater C

Generics Bulletin

Who’s Hired? Lupin Looks To Takeda For Specialty Chief

 
• By Dave Wallace

Lupin has announced the appointment of Claus Jepsen to become president of the Indian firm’s global specialty business, joining the firm from Takeda Pharmaceuticals, where he led the global strategy f

Pink Sheet

OTC Contraceptive Coverage Plan Includes Broader Rx Mandate

 
• By Michael McCaughan

A Biden Administration proposed rule requiring health insurers to cover OTC contraceptives would also require broader access to prescription birth control products, if it moves forward in 2025. The pr